logo

For the Inventor, By the Inventor

Gyeonggi, South Korea

Bong Yong Lee

This inventor holds 4 USPTO granted patents. Top assignees: Yuhan Corporation, Dong-A Pharmaceutical Co., Ltd. Active years: 1992-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bong Yong Lee. Retrieved from https://idiyas.com/inventor/bong-yong-lee-hlte8o5d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Kyunggi-do, KR (2002)
  • Kyonggi-do, KR (2003)
  • Suwon, KR (1992 - 2008)

Company Filing History:

goldMedal4 out of 97 
 
Yuhan Corporation
 patents
silverMedal1 out of 11 
 
Dong-A Pharmaceutical Co., Ltd
 patents
where one patent can have more than one assignee

Years Active: 1992-2008

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7342027 - 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof (2008-03-11),
2. 6545008 - Pyrimidine derivatives and processes for the preparation thereof (2003-04-08),
3. 6352993 - Pyrimidine derivatives and processes for the preparation thereof (2002-03-05),
4. 5089624 - Dihydropyridine derivatives (1992-02-18),

Title: Bong Yong Lee: Innovator in Pharmaceutical Chemistry

Introduction

Bong Yong Lee is a notable inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on developing novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Bong Yong Lee has developed 1-phenylpiperidin-3-one derivatives and processes for their preparation. These derivatives exhibit cysteine protease inhibitory activity and are included in pharmaceutical compositions as active ingredients. Another significant invention is related to pyrimidine derivatives, which possess excellent inhibitory activity against gastric acid secretion. This invention also includes a pharmaceutical composition containing these derivatives and a process for their preparation.

Career Highlights

Bong Yong Lee has worked with prominent companies in the pharmaceutical industry, including Yuhan Corporation and Dong-a Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Bong Yong Lee has collaborated with several professionals in his field, including Jong Wook Lee and Chang Seop Kim. These collaborations have likely enhanced his research and development efforts.

Conclusion

Bong Yong Lee's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…